RARE's IND for UX016, a novel sialic acid prodrug targeting GNEM, a rare muscle disease, gets accepted by the FDA. The ...
I am concerned here more about resultant ugliness involving those ones which should make many doctors smile to the bank after ...
New research into Ozempic and Wegovy has raised fresh concerns for people using popular weight loss drugs, after scientists found a higher risk of bone and tendon-related problems in long-term users, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results